Piper Jaffray Downgrades Questcor Pharmaceuticals (QCOR) to Neutral
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Price: $45.93 +1.64%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade QCOR Now!
Piper Jaffray downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Overweight to Neutral following a U.S. probe into marketing practices. The firm's price target was cut from $67 to $43.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals are down 31.6 percent to $20.60.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals are down 31.6 percent to $20.60.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Howard Weil Downgrades ConocoPhillips (COP) to Sector Perform
- Stifel Nicolaus Downgrades GATX Corp. (GMT) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Piper Jaffray
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
